Strategy
The aim of our research and development activities is to create effective treatment options for medical issues and diseases that have not yet been addressed or adequately researched. Our research is focused on immunotherapeutic treatment approaches based on innovative antibody technologies.

 
Technologies
Innovative antibodies are an essential treatment option in the fight against serious diseases and illnesses. In oncology, they destroy cancer cells, and in transplantation medicine, they help prevent life-threatening organ rejections. Targeted modifications of these immune proteins facilitate the development of more effective and specific antibodies. In several clinical studies, Fresenius Biotech is examining and analyzing the efficacy of new antibodies for various indications.

 
Development
Requirements for the development of new pharmaceuticals are becoming more and more stringent. New technologies and complex medical issues place high demands on study designs and implementation. In a global network, our experts work together on clinical and preclinical research projects in all development phases.

 
Regulatory Approval
All information obtained from toxicological and preclinical studies as well as the data from long-term clinical trials form the basis for the approval process. Our international regulatory affairs team ensures that submission procedures are managed professionally and effectively worldwide.